Co-Founder And Chief Technology Officer (Cto)
Sid created the entire Minimum Viable Product (MVP) on AWS. It's a 100% serverless and multi-tenant application. Despite generating some revenue, more was needed, prompting the company to change its direction. The original product is still in production and generating revenue. Mosaic Biodata's new focus is on medical research technology. Sid exited by selling his equity to private investors and the existing founders.